{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:01:18Z","timestamp":1779120078578,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.4065\/70.3.241","type":"journal-article","created":{"date-parts":[[2012,2,24]],"date-time":"2012-02-24T17:34:43Z","timestamp":1330104883000},"page":"241-246","source":"Crossref","is-referenced-by-count":44,"title":["Clinical Effects of Intravenously Administered Dantrolene"],"prefix":"10.4065","volume":"70","author":[{"given":"Denise J.","family":"Wedel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Iaizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4065\/70.3.241_bib1","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0022-3565(25)30836-0","article-title":"The mechanism of action of dantrolene sodium","volume":"201","author":"Morgan","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"key":"10.4065\/70.3.241_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/bja\/60.3.279","article-title":"Malignant hypcrthermia: dantrolene\u2014dynamics and kinetics","volume":"60","author":"Harrison","year":"1988","journal-title":"Br J Anaesth"},{"key":"10.4065\/70.3.241_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/00000542-198204000-00005","article-title":"Dantrolene in human malignant hyperthermia","volume":"56","author":"Kolb","year":"1982","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1213\/00000539-199308000-00014","article-title":"Malignant hyperthermia: a review of published cases","volume":"77","author":"Strazis","year":"1993","journal-title":"Anesth Analg"},{"key":"10.4065\/70.3.241_bib5","first-page":"388","article-title":"Pharmacology of dantrolene sodium in children","volume":"55","author":"Lietman","year":"1974","journal-title":"Arch Phys Med Rehabil"},{"key":"10.4065\/70.3.241_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000542-198310000-00002","article-title":"Dantrolene dose response in awake man: implications for management of malignant hypcrthermia","volume":"59","author":"Flewellen","year":"1983","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.1975.03240200058032","article-title":"Evaluation of a muscle relaxant: dantrolene sodium (Dantrium)","volume":"231","author":"Dykes","year":"1975","journal-title":"JAMA"},{"key":"10.4065\/70.3.241_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/01480548409014171","article-title":"Hepatotoxicological evaluation of dantrolene sodium","volume":"7","author":"Durham","year":"1984","journal-title":"Drug Chem Toxicol"},{"key":"10.4065\/70.3.241_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000542-198410000-00023","article-title":"Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia [letter]","volume":"61","author":"Flewellen","year":"1984","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00000542-198410000-00024","article-title":"Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia [reply to letter]","volume":"61","author":"Hinkle","year":"1984","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000542-198904000-00013","article-title":"Pharmacokinelics of intravenous dantrolene in children","volume":"70","author":"Lerman","year":"1989","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00003495-197713010-00002","article-title":"Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity","volume":"13","author":"Pinder","year":"1977","journal-title":"Drugs"},{"key":"10.4065\/70.3.241_bib13","first-page":"493","article-title":"Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report","volume":"88","author":"Free","year":"1978","journal-title":"N Z Med J"},{"issue":"Suppl","key":"10.4065\/70.3.241_bib14","first-page":"A1079","article-title":"North American Malignant Hyperthermia Registry. Safety and efficacy of dantrolene sodium in the treatment of malignant hypcrthermia events [abstract]","volume":"79","author":"Larach","year":"1993","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1213\/00000539-198506000-00008","article-title":"Verapamil isnota therapeutic adjunct to dantrolene in porcine malignant hypcrthermia","volume":"64","author":"Gallant","year":"1985","journal-title":"Anesth Analg"},{"key":"10.4065\/70.3.241_bib16","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1213\/00000539-198603000-00006","article-title":"Effects of dantrolene and vcrapamil on atrioventricular conduction and cardiovascular performance in dogs","volume":"65","author":"Lynch","year":"1986","journal-title":"Anesth Analg"},{"key":"10.4065\/70.3.241_bib17","first-page":"473","article-title":"Hyperkalemia and cardiovascular collapse after verapamil and dantrolene administration in swine","volume":"63","author":"Saltzman","year":"1984","journal-title":"AnesthAnalg"},{"key":"10.4065\/70.3.241_bib18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mus.880131003","article-title":"Multiple-pulse stimulation and dantrolene in malignant hypcrthermia","volume":"13","author":"Quinlan","year":"1990","journal-title":"Muscle Nerve"},{"key":"10.4065\/70.3.241_bib19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00000542-198505000-00022","article-title":"Femoral block with mepivacainc for muscle biopsy in malignant hypcrthermia patients","volume":"62","author":"Berkowitz","year":"1985","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1399-6576.1986.tb02479.x","article-title":"3-in-l lumbar plexus block for muscle biopsy in malignant hyperthermia patients: amide local anaesthetics may be used safely","volume":"30","author":"Gielen","year":"1986","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.4065\/70.3.241_bib21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1399-6576.1991.tb03377.x","article-title":"Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia","volume":"35","author":"\u00d8rding","year":"1991","journal-title":"Acta Anaeslhesiol Scand"},{"key":"10.4065\/70.3.241_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/019459989110500508","article-title":"Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene","volume":"105","author":"Derkay","year":"1991","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.4065\/70.3.241_bib23","first-page":"87","article-title":"Anesthesia in malignant hyperthermia susceptible patients","volume":"41","author":"Mauritz","year":"1990","journal-title":"Acta Anaesthesiol Belg"},{"key":"10.4065\/70.3.241_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1399-6576.1990.tb03140.x","article-title":"Anaesthesia in malignant hyperthcrmia-susceptible patients without dantrolene prophylaxis: a report of 30 cases","volume":"34","author":"Hackl","year":"1990","journal-title":"Acta Anaeslhesiol Scand"},{"key":"10.4065\/70.3.241_bib25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00000542-199004000-00007","article-title":"Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility","volume":"72","author":"Allen","year":"1990","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3468(89)80239-8","article-title":"Malignant hyperthermia: experience in the prospective management of eight children","volume":"24","author":"Dubrow","year":"1989","journal-title":"J Pediatr Surg"},{"key":"10.4065\/70.3.241_bib27","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0310057X9202000427","article-title":"Prolonged malignant hyperthermia in the absence of triggering agents","volume":"20","author":"Pollock","year":"1992","journal-title":"Anaesth Intensive Care"},{"key":"10.4065\/70.3.241_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03013807","article-title":"Postoperative malignant hyperthermia episodes in patients who received \u201csafe\u201d anaesthetics","volume":"30","author":"Grinberg","year":"1983","journal-title":"Can Anaesth Soc J"},{"key":"10.4065\/70.3.241_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00000542-198101000-00014","article-title":"Malignant hyperthermia following preoperalive oral administration of dantrolene","volume":"54","author":"Fitzgibbons","year":"1981","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00000542-198402000-00017","article-title":"Malignant hyperthermia after oral and intravenous presentment with dantrolene in a patient susceptible to malignant hyperthermia","volume":"60","author":"Ruhland","year":"1984","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1213\/00000539-198005000-00011","article-title":"Human malignant hyperthermia: awake episodes and correction by dantrolene","volume":"59","author":"Gronert","year":"1980","journal-title":"Anesth Analg"},{"key":"10.4065\/70.3.241_bib32","first-page":"623","article-title":"Dantrolene sodium in traumatic muscle contracture: double-blind clinical and pharmacological trial","volume":"11","author":"Flacco","year":"1989","journal-title":"Clin Ther"},{"key":"10.4065\/70.3.241_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9378(88)80147-9","article-title":"Dantrolene in pregnancy: lack of adverse effects on the fetus and newborn infant","volume":"159","author":"Shime","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.4065\/70.3.241_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00000542-198609000-00012","article-title":"Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia","volume":"65","author":"Watson","year":"1986","journal-title":"Anesthesiology"},{"key":"10.4065\/70.3.241_bib35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2460\/javma.1990.197.08.1051","article-title":"Prophylactic use of dantrolene associated with prolonged poslanesthetic recumbency in a horse","volume":"197","author":"Valverde","year":"1990","journal-title":"J Am Vet Med Assoc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611649434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611649434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T18:50:37Z","timestamp":1742583037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611649434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0025619611649434"],"URL":"https:\/\/doi.org\/10.4065\/70.3.241","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}